Asset
Zopapogene Imadenovec
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT06538480 | phase4 | recruiting | 2024-07-11 | 2027-12-02 | Precigen, Inc | Zopa Retreatment and Vector Shedding in Adults With RRP |
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| BLA 125832 | BLA | Precigen, Inc. |
Marketed products (1)
- PAPZIMEOS